Lamisil
NDC Package 0067-6171-85
Package Information
Lamisil is a medication used to treat a variety of fungal skin infections such as ringworm, athlete's foot, and jock itch. Marketed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc, this product is identified by NDC 0067-6171 and is authorized under FDA application NDA020980.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0067 - Glaxosmithkline Consumer Healthcare Holdings (us) Llc
- 0067-6171 - Lamisil
- 0067-6171-85 - 1 TUBE in 1 CARTON / 24 g in 1 TUBE
- 0067-6171 - Lamisil
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0067-6171-85 identifies a specific commercial package of 1 tube in 1 carton / 24 g in 1 tube of Lamisil AT, labeled by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. This product is billed per "GM" gram and contains an estimated amount of 24 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Glaxosmithkline Consumer Healthcare Holdings (us) Llc on August 10, 2005. The current certification is valid through September 30, 2013.
What are the primary indications for this medication?
This medication is used to treat a variety of fungal skin infections such as ringworm, athlete's foot, and jock itch. This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Terbinafine is an antifungal that works by preventing the growth of fungus.
How is this Glaxosmithkline Consumer Healthcare Holdings (us) Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00067617185. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 24 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.